印尼总统见证志愿者注射中国疫苗 — President of Indonesia Witnessed Volunteers were Injected the Chinese Vaccines

(讯报雅加达讯)佐科威总统(Joko Widodo)说,政府目前正在研发2019冠状病毒病(Covid-19)疫苗。疫苗开发是在印尼与其他国家合作之外进行的。佐科威估计,这种称为红白疫苗(vaksin Merah Putih)的疫苗将在明年年中完成。

佐科威11日(星期二)在西爪哇万隆巴查查兰大学(Universitas Padjadjaran)审查冠病疫苗的III期临床试验时说:“我们希望红白疫苗能够尽快完成,并有望在2021年中期完成。”

佐科威说,红白疫苗是在过去三个月内开发的。该疫苗是从印尼流通的冠状病毒开发的。参与开发这种疫苗的许多机构是艾克曼分子生物研究所(Eijkman Institute for Molecular Biology),技术评估和应用局(BPPT),印尼科学院(LIPI),食品药物监督管理局(BPOM),研究和科技部以及许多大学。

佐科威说:“因此,我们充分开发了自己的产品。”然而,印尼继续与其他国家/地区开展合作。其中之一是来自中国的科兴控股生物技术有限公司(Sinovac Biotech., Ltd.)。

Sinovac 疫苗已在其母国通过了I和II期临床试验,并于11日在位于万隆巴查查兰大学医院正式启动开始了III期临床试验。疫苗注射给1,620名志愿者,并由佐科威总统进行了见证。

佐科威总统在星期二下午在总统秘书处YouTube上播出的节目中说:“今天,我在Unpad的万隆医学院,以便亲眼目睹为1,620名志愿者实施的首个免疫注射方案。”

除中国外,印尼还与其他许多国家开展了合作。佐科威说:“与阿拉伯联合酋长国在G-42上合作,与韩国合作。我认为我们正在为所有印尼人接种疫苗的立即可能性框架内开放。”

佐科威说:“我们正在尽快开放自己,我们可以为所有印尼人民接种疫苗。我们乐观地认为,一旦发现这种疫苗,我们就可以为所有人接种疫苗。”

冠病疫苗临床试验团队发言人介绍,在接种疫苗之前,巴查查兰大学医学院的研究小组将检查志愿者的健康状况,包括体检,病史,专科医生面试。健康检查后三天(8月14日),志愿者将接种疫苗。之后,研究小组将对符合条件的志愿者注射新冠病毒(SARS Cov-2)或安慰剂疫苗。

志愿者将在14天后再次接种相同的剂量,随后研究小组将采集志愿者的血液样本。临床试验持续了六个月。共有1,020人已经注册为新冠9疫苗志愿者,西爪哇省长李特万(RidwanKamil)就是其中之一。(Int/weetness)

(Jakarta News) President Joko Widodo said that the government is currently developing a vaccine for the Coronavirus Disease 2019 (Covid-19). Vaccine development is carried out in cooperation with other countries outside Indonesia. Jokowi estimates that the vaccine, called vaksin Merah Putih, will be completed in the mid of next year.

On Tuesday, 11th August,  Jokowi said in his review of the Phase III clinical trial of the Covid-19 vaccine at Universitas Padjadjaran in Bandung, West Java, “We hope that the vaksin Merah Putih can be completed as soon as possible, and is expected to be completed in the mid of 2021.”

Jokowi said that the vaksin Merah Putih  was developed in the past three months. The vaccine was developed from the Covid-19 virus circulating in Indonesia. Several institutions involved in the development of this vaccine are Eijkman Institute for Molecular Biology, Evaluation and Application Bureau of Technology (BPPT), Indonesian Academy of Sciences (LIPI), Food and Drug Administration (BPOM), Ministry of Research and Technology and also many universities.

He said, “Therefore, we have fully developed our own products.” However, Indonesia continues to cooperate with other countries and regions. One of them is Sinovac Biotech., Ltd. from China.

Sinovac vaccine has passed Phase I and Phase II clinical trials in its home country, and officially launched third phase clinical trials at the Padjajaran University Research Hospital in Bandung on the 11th this month. The vaccine was injected to 1,620 volunteers and was witnessed by President Jokowi.

President Jokowi said in a program broadcasted on the YouTube of the President’s Secretariat on Tuesday afternoon, “Today, I am at the Bandung Medical Faculty of UNPAD to witness the first immunization injection program for 1,620 volunteers.”

Except with China, Indonesia has also cooperated with many other countries. Jokowi said, “We cooperate with the United Arab Emirates on G-42 and work with South Korea. I think we are opening the framework of the immediate possibility of vaccination to all Indonesians.”

Jokowi said: “We are opening ourselves up as soon as possible and we can vaccinate all Indonesian people. We are optimistic that once this vaccine is discovered, we can vaccinate everyone.”

The spokesperson of the Covid-19 Vaccine Clinical Trial Team introduced that before the vaccination, the research team of the UNPAD Faculty of Medicine will check the health of the volunteers, including physical examination, medical history, and interview with a specialist. Three days after the health examination (on August 14), the volunteers will be vaccinated. After that, the research team will inject the Covid-19 (SARS Cov-2) or placebo vaccines on the eligible volunteers for the next stage clinical trial.

The volunteers will be vaccinated again with the same dose 14 days later, and then the research team will collect blood samples from the volunteers. The clinical trial will last for six months. A total of 1,020 people have been registered as COVID-19 vaccine volunteers, and West Java Governor Ridwan Kamil is one of them.

Reference:
1..https://setneg.go.id/baca/index/tinjau_fasilitas_produksi_bio_farma_presiden_indonesia_mampu_produksi_vaksin_sendiri
2. https://mp.weixin.qq.com/s/i5poUnjpbVNeFSGEDB3Z5A
3. https://nasional.kompas.com/read/2020/08/11/16041691/jokowi-tinjau-fasilitas-produksi-vaksin-covid-19-milik-bio-farma
4. https://kabar24.bisnis.com/read/20200811/15/1277691/jokowi-vaksin-merah-putih-buatan-indonesia-rampung-2021

Leave a Reply

Your email address will not be published. Required fields are marked *